TP53 and carcinosarcoma: Because IHC for p53 was not universally performed at the time this study began, the only inclusion criteria were a biopsy-proven SEC (n = 12), high grade endometrioid EC (n = 4), or carcinosarcoma (n = 4) (Supplemental Table 4).